The firm will use the grant to accelerate the commercialization of synthetic DNA standards and algorithms licensed from the University of Minnesota.
In PLOS this week: links between gut microbiome and colorectal cancer mutations, targeted sequencing uncovers genetic susceptibilities to epilepsy in Koreans, and more.
In PLOS this week: de novo mutations in epileptic encephalopathy, sequencing analysis of aromatic rice, and more.
In PLOS this week: approach to diagnose hemorrhagic fevers, recessive disease mutations in mixed-breed dogs, and more.
In PLOS this week: biobank for sleeping sickness research, skin microbiome of cats with allergies, and more.
Roughly one-third of castration-resistant prostate cancer cases appear to involve rearrangements affecting the androgen receptor gene.
The University of Minnesota's Shilpa Gupta will work with Biocept on a study aimed at providing clinical support for the use of the firm's PD-L1 and AR tests.
CRISPR is the paradigm now in research applications, but companies with IP rights to TALENs and zinc finger nucleases are pushing forward with those technologies.
A group from the University of Minnesota found that quantitative and qualitative errors in NGS library prep could be eliminated by changing four parameters in a common workflow.
The researchers have received $2 million to support three years of study and the production of legal guidelines for translating genomic medicine into clinical applications.
Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.
Retraction Watch's Ivan Oransky and Adam Marcus report that Harvard Medical School and Brigham and Women's Hospital have recommended that more than 30 papers from a former researcher be retracted.
Thomas Steitz, who won the 2009 chemistry Nobel Prize for his ribosome work, has died, the Washington Post reports.
In PLOS this week: mechanisms for genes implicated in coronary artery disease, rumen microbes and host genetics influence cow methane production, and more.